Drug results: 1

tasimelteon an agonist at melatonin MT1 and MT2 receptors, these receptors are thought to be involved in the control of circadian rhythms

Featured News

Drugcentral 2023 NAR Article

The Latest in Chemistry in Coronavirus Research


Drugs in the News


Makena Venetoclax Dapagliflozin KEYTRUDA Sacubitril LORBRENA Hydroxychloroquine


DrugCentral Search Overview